IBIO - iBio, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
6/30/2019
6/30/2018
6/30/2017
Total Revenue
1,313
2,018
444
394
Operating Expense
16,440
17,806
14,671
14,668
Operating Income
-15,127
-15,788
-14,227
-14,274
Net Non Operating Interest Income Expense
-2,302
-1,825
-1,900
-1,890
Other Income Expense
21
16
19
25
Pretax Income
-17,408
-17,597
-16,108
-16,139
Net Income Common Stockholders
-39,225
-17,853
-16,365
-14,622
Diluted NI Available to Com Stockholders
-39,225
-17,853
-16,365
-14,622
Basic EPS
-
0
-0.0015
-0.0016
Diluted EPS
-
0
-0.0015
-0.0016
Basic Average Shares
-
18,926
10,631
8,911
Diluted Average Shares
-
18,926
10,631
8,911
Total Operating Income as Reported
-15,127
-15,788
-14,227
-14,274
Total Expenses
16,440
17,806
14,671
14,668
Net Income from Continuing & Discontinued Operation
-17,404
-17,593
-16,105
-14,532
Normalized Income
-17,404
-17,593
-16,105
-14,532
Interest Income
23
75
15
39
Interest Expense
2,325
1,900
1,915
1,929
Net Interest Income
-2,302
-1,825
-1,900
-1,890
EBIT
-15,083
-15,697
-14,193
-14,210
EBITDA
-12,964
-
-
-
Reconciled Depreciation
2,119
1,749
1,709
1,676
Net Income from Continuing Operation Net Minority Interest
-17,404
-17,593
-16,105
-14,532
Normalized EBITDA
-12,964
-13,948
-12,484
-12,534
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0